http://feeds.harvardbusiness.org/~r/harvardbusiness/~3/EjnEtUKFaMg/how-johnson-johnson-made-hard-decisions-during-covid
The company had to decide: Should a drug designed to treat HIV patients be diverted to people with Covid-19 instead?
How Johnson & Johnson Made Hard Decisions During Covid
Published in Business and Uncategorized
More from BusinessMore posts in Business »
- Gold ends week higher despite Powell’s pushback, trade uncertainty lingers
- EUR/USD climbs as US Dollar weakens on trade tensions
- Forex Today: Markets stabilize as trading volume thins out on Easter Friday
- US Dollar Index hovers near 99.50 as trading activity remains muted due to Good Friday
- Follow the leaders
- Starbucks gets a new dress code, Tesla falls behind, and Trump wants Powell out: Business news roundup
- Tumbling stocks, recession fears, and a retail sales surge: Markets news roundup
- Meta’s antitrust trial, Nvidia’s stateside manufacturing, and 7 AI breakthroughs: Tech news roundup
- Meta’s antitrust trial heats up: Here’s what we’ve learned so far
- Eli Lilly promises to make new weight loss pill in the U.S.
More from UncategorizedMore posts in Uncategorized »
- Gold ends week higher despite Powell’s pushback, trade uncertainty lingers
- EUR/USD climbs as US Dollar weakens on trade tensions
- Forex Today: Markets stabilize as trading volume thins out on Easter Friday
- US Dollar Index hovers near 99.50 as trading activity remains muted due to Good Friday
- Follow the leaders
- Starbucks gets a new dress code, Tesla falls behind, and Trump wants Powell out: Business news roundup
- Tumbling stocks, recession fears, and a retail sales surge: Markets news roundup
- Meta’s antitrust trial, Nvidia’s stateside manufacturing, and 7 AI breakthroughs: Tech news roundup
- Meta’s antitrust trial heats up: Here’s what we’ve learned so far
- Eli Lilly promises to make new weight loss pill in the U.S.